Use of microRNA let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Jin, Huajun ^a,b   Lv, Saiqun ^a   Yang, Jiahe ^a   Wang, Xiaoning ^b   Hu, Huanzhang ^a   Su, Changqing ^a   Zhou, Chengliang ^a   Li, Jiang ^a   Huang, Yao ^a   Li, Linfang ^a   Liu, Xinyuan ^c   Wu, Mengchao ^a   Qian, Qijun ^a,c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^c ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7; MICRORNA; ONCOLYTIC ADENOVIRUS; PLACEBO; UNCLASSIFIED DRUG; E1A PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LUCIFERASE; MESSENGER RNA; MIRNLET7 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; E1A GENE; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROTEIN EXPRESSION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION; ADENOVIRUS; ADENOVIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; DRUG SCREENING; ENZYME IMMUNOASSAY; FEMALE; GENE VECTOR; GENETICS; LIVER; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; NUDE MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

ADENOVIRIDAE; MUS;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADENOVIRUS E1A PROTEINS; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; ONCOLYTIC VIROTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960644093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021307     Document Type: Article

References (45)

1. Roberts LR, (2008) Sorafenib in liver cancer-just the beginning. N Engl J Med 359 (4): 420-422.
2. Tung-Ping Poon R, Fan ST, Wong J, (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232 (1): 10-24.
3. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (5): 1164-1171.
4. Lai EC, (2002) MicroRNAs are complementary to 3′UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30 (4): 363-364.
5. Herranz H, Cohen SM, (2010) MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev 24 (13): 1339-1344.
6. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, et al. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (6772): 901-906.
7. Roush S, Slack FJ, (2008) The let-7 family of microRNAs. Trends Cell Biol 18 (10): 505-516.
8. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ, (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1 (12): 882-891.
9. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64 (11): 3753-3756.
10. Akao Y, Nakagawa Y, Naoe T, (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29 (5): 903-906.
11. Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H, (2007) Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67 (21): 10117-10122.
12. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, et al. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67 (24): 11612-11620.
13. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, et al. (2008) Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 14 (8): 2334-2340.
14. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M, (2008) MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18 (5): 549-557.
15. Sampson VB, Rong NH, Han J, Yang Q, Aris V, et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67 (20): 9762-9770.
16. Mi S, Lu J, Sun M, Li Z, Zhang H, et al. (2007) MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 104 (50): 19971-19976.
17. Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, et al. (2007) The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 52 (5): 698-704.
18. Ji J, Zhao L, Budhu A, Forgues M, Jia HL, et al. (2010) Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 52 (5): 690-697.
19. Lan FF, Wang H, Chen YC, Chan CY, Ng SS, et al. (2011) Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16 (INK4A). Int J Cancer 128 (2): 319-331.
20. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19 (2): 232-243.
21. Büssing I, Slack FJ, Grosshans H, (2008) let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14 (9): 400-409.
22. Barh D, Malhotra R, Ravi B, Sindhurani P, (2010) Microrna let-7: an emerging next-generation cancer therapeutic. Curr Oncol 17 (1): 70-80.
23. Wang V, Wu W, (2009) MicroRNA-based therapeutics for cancer. BioDrugs 23 (1): 15-23.
24. Bell JC, Kirn D, (2008) MicroRNAs fine-tune oncolytic viruses. Nat Biotechnol 26 (12): 1346-1348.
25. Edge RE, Falls TJ, Brown CW, Lichty BD, Atkins H, et al. (2008) A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol Ther 16 (8): 1437-1443.
26. Kelly EJ, Hadac EM, Greiner S, Russell SJ, (2008) Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 14 (11): 1278-1283.
27. Ylösmäki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, et al. (2008) Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol 82 (22): 11009-11015.
28. Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, et al. (2009) Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog 5 (5): e1000440.
29. Rowan K, (2010) Oncolytic viruses move forward in clinical trials. J Natl Cancer Inst 102 (9): 590-595.
30. Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML, et al. (2010) Adenovirus-mediated cancer gene therapy and virotherapy. Int J Mol Med 25 (1): 3-10.
31. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, et al. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274 (5286): 373-376.
32. Heise C, Hermiston T, Johnson L, Brooks G, Sampson-Johannes A, et al. (2000) An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med 6 (10): 1134-1139.
33. Zhang Q, Nie M, Sham J, Su C, Xue H, et al. (2004) Effective gene-viral therapy for telomerase-positive cancers by selective replication-competent adenovirus combining with endostatin gene. Cancer Res 64 (15): 5390-5397.
34. Zhang Q, Chen G, Wang X, Peng L, Liu C, et al. (2006) Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Clin Cancer Res 12 (21): 6523-6531.
35. Wang X, Su C, Cao H, Li K, Chen J, et al. (2008) A novel triple-regulated oncolytic adeno-virus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers. Mol Cancer Ther 7 (6): 1598-1603.
36. Wang G, Li G, Liu H, Yang C, Yang X, et al. (2009) E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. J Gene Med 11 (6): 477-485.
37. Poulin KL, Lanthier RM, Smith AC, Christou C, Risco Quiroz M, et al. (2010) Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. J Virol 84 (19): 10074-10086.
38. Seregin SS, Aldhamen YA, Appledorn DM, Hartman ZC, Schuldt NJ, et al. (2010) Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo. Blood 116 (10): 1669-1677.
39. Hamid O, Varterasian ML, Wadler S, Hecht JR, Benson A 3rd, et al. (2003) Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer. J Clin Oncol 21 (8): 1498-1504.
40. Wakiyama M, Takimoto K, Ohara O, Yokoyama S, (2007) Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev 21 (15): 1857-1862.
41. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME, (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17 (1): F19-36.
42. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (6): 1109-1123.
43. Guo Y, Chen Y, Ito H, Watanabe A, Ge X, et al. (2006) Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384: 51-61.
44. Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, et al. (2010) Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 31 (9): 1516-1522.
45. Kong YW, Cannell IG, de Moor CH, Hill K, Garside PG, et al. (2008) The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci U S A 105 (26): 8866-8871.